<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union</dc:title>
  <dc:creator>Tall, A.</dc:creator>
  <dc:creator>Rabarijaona, L. P.</dc:creator>
  <dc:creator>/Robert, Vincent</dc:creator>
  <dc:creator>Bedja, S. A.</dc:creator>
  <dc:creator>Ariey, F.</dc:creator>
  <dc:creator>Randrianarivelojosia, M.</dc:creator>
  <dc:subject>malaria</dc:subject>
  <dc:subject>Comoros union</dc:subject>
  <dc:subject>ACT</dc:subject>
  <dc:subject>artesunate</dc:subject>
  <dc:subject>amodiaquine</dc:subject>
  <dc:subject>drug policy</dc:subject>
  <dc:description>Health policy makers in Comoros Union have considered a policy change recommending combination treatment to control malaria. We evaluated the efficacy of three antimalarial drug combinations, taken orally, to enable the authorities to make an evidence-based choice. The study was carried out in patients of 2-70 years old in Moroni, Moheli and Anjouan in 2003. We enrolled 168 patients with uncomplicated malaria from 1097 outpatients screened at the health centres. One hundred and fifty-eight patients, of whom half were under five years old, (mean age = 11.1 +/- 13.9 years), were followed up for 14 days. According to PCR adjusted outcome, the therapeutic efficacy of artesunate + amodiaquine (AS + AQ) (n = 54) and artesunate + sulfadoxine-pyrimethamine (AS + SP) (n = 53) was 100%, whereas that of chloroquine + sulfadoxine-pyrimethamine (CQ + SP) was 98% (50/51). The key difference between these treatments was the higher parasite clearance rate on Day 2 obtained with artesunate-containing combinations (P &lt; 0.001). These results provide a baseline for monitoring changes in the susceptibility of Plasmodium falciparum to artesunate+amodiaquine and artesunate + sulfadoxine-pyrimethamine (ACTs) in the Comoros Union. Health policy changes involving the replacement of chloroquine in the Indian Ocean subregion are discussed.</dc:description>
  <dc:date>2007</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010040714</dc:identifier>
  <dc:identifier>fdi:010040714</dc:identifier>
  <dc:identifier>Tall A., Rabarijaona L. P., Robert Vincent, Bedja S. A., Ariey F., Randrianarivelojosia M.. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union. 2007, 102 (3),  176-181</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
